Reference Hub

Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb: Examining the Association of Severity and Treatment Regimens with Costs and Annual Bleed Rates

In this article are presented the results of a survey provided to patients with hemophilia B to determine the US societal burden of illness, including direct and indirect costs and annual bleed rate (ABR), followed by examination of associations between hemophilia severity and treatment regimens with costs and ABR. From the Hematology Utilization Group Study (HUGS), internationally recognized US HTC Research Collaborative Examining cost illness burden.

Author(s):
Chen, Baker, Nichol
Date:
September, 2017

Document Type:

Publications
Updated on June 28, 2022
Enter your search criteria to find works by title, author, keyword(s), or date.